• A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy  

    Griffin PT; Komrokji RS; De Castro CM; Rizzieri DA; Melchert M; List AF; Lancet JE, American Journal of Hematology, 1/1/2015

  • A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma  

    Held LA. Rizzieri D. Long GD. Gockerman JP. Diehl LF. de Castro CM. Moore JO. Horwitz ME. Chao NJ. Gasparetto C, Cancer Investigation, 1/1/2013

  • Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria  

    Hillmen P, Muus P, Roth A, Elebute MO, Risitanon AM, Schrezenmeter H, Szer J, Browne P, Maciejewski JP, Schubert J, Urbano-Ispizua A, de Castro C, Socie G, Brodsky RA, Brit J Haematol, 1/1/2013
  • Join now to see all